Nasdaq:CPRX

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025

CORAL GABLES, Fla., April 22, 2025 (GLOBE NEWSWIRE) --  Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company…

2 weeks ago
Catalyst Pharmaceuticals Recognized as One of North Americas Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500 ListCatalyst Pharmaceuticals Recognized as One of North Americas Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500 List

Catalyst Pharmaceuticals Recognized as One of North Americas Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500 List

CORAL GABLES, Fla., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), today announced it ranked number…

5 months ago